Skip to content

ENDOGYN

Active
Private limited companyfounded 20242 yrs activeTienne aux Clochers(WP) 140, 5100 Namur, BelgiumKBO/BCE: BE 1011.001.306
Summary

The computed 12-month bankruptcy probability of ENDOGYN is 3.5% (moderate). The 2024 annual accounts show equity of €25,600 and a net result of €25,500. The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2024
Axes
Profitability100
Solvency82
Growth-
Track record67
Bankruptcy probability, 12 months
3.5% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €1,500 at 30 days acceptable
Liquidity ample (current ratio 1.85; short-term debt: 42.4% and cash: 22.8% of total assets), and 42.7% of the assets are financed with debt.
Credit check for your own amount and term

Open the credit simulator : see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 y
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024
Solvency, return and age of the figures
Solvency
57.3%
Return on assets
57%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 20-06-2025, 41 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2024
41 d early
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its 2024 accounts 41 days before the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

ENDOGYN was incorporated on 1 July 2024 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2024.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2024

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, micro schema

Equity
€25,600
Total assets
€44,716
Net result
€25,500
Working capital
€16,096

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €44,716
Fixed assets €9,658
Current assets €35,058
Equity and liabilities €44,716
Equity €25,600
Debt €19,115
Debt finances 42.7% of the balance-sheet total.
Key figures and ratios
2024 value
EBITDA
€32,727
Cash flow
€25,843
Current ratio
1.85
Debt to equity
0.75
ROE
99.6%
ROA
57.0%
Interest coverage
171.36
Debt ≤ 1 year
€18,962
Income taxes
€6,693
Annual accounts
Filed annual accounts As filed with the NBB · 2024 · 30 lines
Balance sheet Code2024
Assets
Total assets20/58€44,716
Fixed assets21/28€9,658
Tangible fixed assets22/27€9,658
Furniture and vehicles24€9,658
Current assets29/58€35,058
Cash at bank and in hand54/58€10,196
Deferred charges and accrued income490/1€24,862
Equity and liabilities
Total equity and liabilities10/49€44,716
Equity10/15€25,600
Contributions10/11€100
Profit (loss) carried forward14€25,500
Amounts payable17/49€19,115
Amounts payable within one year42/48€18,962
Trade debts44€628
Suppliers440/4€628
Taxes, remuneration and social security45€6,693
Taxes450/3€6,693
Other amounts payable47/48€11,641
Accrued charges and deferred income492/3€153
Income statement Code2024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€342
Other operating charges640/8€387
Gross operating margin9900€33,114
Operating profit (loss)9901€32,384
Financial charges65/66B€191
Recurring financial charges65€191
Profit (loss) for the period before taxes9903€32,193
Income taxes67/77€6,693
Profit (loss) for the period9904€25,500
Profit (loss) for the period to be appropriated9905€25,500
Appropriation of the result
Profit (loss) to be appropriated9906€25,500

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€342
Other operating charges640/8€387
Gross operating margin9900€33,114
Operating profit (loss)9901€32,384
Financial charges65/66B€191
Recurring financial charges65€191
Profit (loss) for the period before taxes9903€32,193
Income taxes67/77€6,693
Profit (loss) for the period9904€25,500
Profit (loss) for the period to be appropriated9905€25,500
Line2024
Assets
Total assets20/58€44,716
Fixed assets21/28€9,658
Tangible fixed assets22/27€9,658
Furniture and vehicles24€9,658
Current assets29/58€35,058
Cash at bank and in hand54/58€10,196
Deferred charges and accrued income490/1€24,862
Equity and liabilities
Total equity and liabilities10/49€44,716
Equity10/15€25,600
Contributions10/11€100
Profit (loss) carried forward14€25,500
Amounts payable17/49€19,115
Amounts payable within one year42/48€18,962
Trade debts44€628
Suppliers440/4€628
Taxes, remuneration and social security45€6,693
Taxes450/3€6,693
Other amounts payable47/48€11,641
Accrued charges and deferred income492/3€153
Line2024
Profit (loss) for the period9904€25,500
+ Depreciation and write-downs630€342
Operating cash flow (approximation)€25,843

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
20-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
NBB filing
0 of 2 acts read
About the unread acts

We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Namur · 1 establishment unit since 2024
seat establishment The establishment unit on the map
Ground area
6,273 m²
Building footprint
313 m²
Volume, LiDAR
1,825 m³
2 parcels, Flanders, Wallonia · tallest building 8.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
ENDOGYN
Varenslaan 34, 3090 OverijseSpecialist medical practice
since 20242.373.938.309
2 parcels
Flanders 1 (50%) Wallonia 1 (50%)
Parcel (capakey) Region Area Buildings Height / fl.
92135H0190/00K000 Wallonia 4,512 m² 1 · 199 m² 8.3 m · 2 fl.
23543K0085/00Y020 Flanders 1,761 m² 1 · 115 m² 7.3 m · 2 fl.
Linked by address, not proof of ownership
Good to know
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Legal Entity Identifier

254900I7TV98UAC1CC24
live in the LEI register

Identification & contact

Identification
Legal formPrivate limited company
Founded01-07-2024
Fiscal year end31-12

Scores and ratios are computed by Checked and are not a credit decision.